Access the full text.
Sign up today, get DeepDyve free for 14 days.
T. Nagashima, S. Onishi, Y. Kamata, S. Minota (2009)
Dermatomyositis associated with thyroid cancer: a paraneoplastic syndrome?Rheumatology International, 29
E. Comby, Pascale Tanaff, D. Mariotte, Valérie Costentin-Pignol, C. Marcelli, J. Ballet (2006)
Evolution of antinuclear antibodies and clinical patterns in patients with active rheumatoid arthritis with longterm infliximab therapy.The Journal of rheumatology, 33 1
U. Kiltz, C. Fendler, J. Braun (2008)
Neuromuscular involvement in rheumatic patients treated with anti-tumor necrosis factor therapy--three examples.The Journal of rheumatology, 35 10
M. Ramos-Casals, P. Brito‐Zerón, S. Muñoz, N. Soria, Diana Galiana, L. Bertolaccini, M. Cuadrado, M. Khamashta (2007)
Autoimmune Diseases Induced by TNF-Targeted Therapies: Analysis of 233 CasesMedicine, 86
Y. Urata, Y. Wakai, K. Kowatari, T. Nitobe, Y. Mizushima (2006)
Polymyositis associated with infliximab treatment for rheumatoid arthritisModern Rheumatology, 16
T. Nagashima, M. Iwamoto, S. Minota (2011)
Antisynthetase syndrome associated with long-standing rheumatoid arthritisRheumatology International, 31
E. Martínez‐Cordero, D. León, L. Ortega (2001)
Association of polymyositis with rheumatoid arthritisRheumatology International, 20
C. Marguerie, C. Bunn, H. Beynon, R. Bernstein, J. Hughes, A. So, M. Walport (1990)
Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes.The Quarterly journal of medicine, 77 282
W. Schmidt, W. Wetzel, R. Friedländer, R. Lange, H. Sörensen, H. Lichey, E. Genth, R. Mierau, E. Gromnica-Ihle (2000)
Clinical and Serological Aspects of Patients with Anti-Jo-1 Antibodies – an Evolving Spectrum of Disease ManifestationsClinical Rheumatology, 19
Y. Ishikawa, N. Yukawa, K. Ohmura, Y. Hosono, Y. Imura, D. Kawabata, T. Nojima, T. Fujii, T. Usui, T. Mimori (2010)
Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literatureClinical Rheumatology, 29
(2000)
Clinical and serological aspects of patients with anti-Jo-1 antibodies—an evolving spectrum of disease
Clin Rheumatol (2010) 29:819–820 DOI 10.1007/s10067-010-1467-6 LETTER TO EDITOR Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment? Takao Nagashima & Seiji Minota Received: 6 April 2010 /Accepted: 7 April 2010 /Published online: 20 April 2010 Clinical Rheumatology 2010 Dear Editor, misdiagnosed as RA. Overlap of ASS and classical RA can We read the recent article by Ishikawa et al. [1] “Etanercept- also occur [4]. If such patients are treated for RA with TNF induced anti-Jo-1-antibody-positive polymyositis in a patient antagonists and subsequently develop myositis, it becomes with rheumatoid arthritis: a case report and review of the difficult to decide whether this has been induced by the TNF literature” with great interest. We would like to make some antagonist or is related to ASS. comments about the development of myositis in relation to They also speculated that patients with some background anti-tumor necrosis factor (TNF) therapy. risks (positivity for antinuclear antibody (ANA) or anti-Jo-1 An association of polymyositis (PM)/dermatomyositis antibodies) tend to develop autoimmune phenomena during (DM) with rheumatoid arthritis (RA) has long been well- therapy with TNF antagonists [1]. Anti-TNF therapy has been known [2]. We recently reported two RA
Clinical Rheumatology – Springer Journals
Published: Apr 20, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.